Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-22,194
Closed -$546K 4226
2018
Q1
$546K Buy
+22,194
New +$583K ﹤0.01% 2486
2017
Q2
Sell
-18,799
Closed -$397K 4465
2017
Q1
$353K Buy
18,799
+9,291
+98% +$146K ﹤0.01% 2564
2016
Q4
$138K Buy
+9,508
New +$129K ﹤0.01% 3641
2014
Q2
Sell
-13,464
Closed -$116K 4538
2014
Q1
$116K Sell
13,464
-5,736
-30% -$52.8K ﹤0.01% 3822
2013
Q4
$187K Buy
19,200
+4,265
+29% +$38.7K ﹤0.01% 3566
2013
Q3
$63.1K Buy
+14,935
New +$121K ﹤0.01% 4424

Other funds holding ACLS

PEAK6 Group's ACLS Position: Q2 2018 in Review

PEAK6 Group sold out of Axcelis (ACLS) in Q2 2018, closing a stake of 22,194 shares — an estimated $546K sold.

PEAK6 Group first reported a position in ACLS in Q3 2013 and held it in 6 quarters. The position peaked at $546K in Q1 2018. 165 funds tracked by Wall St. Rank hold ACLS as of Q2 2018.

  • PEAK6 Group reported no remaining Axcelis position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 22,194 Axcelis shares in Q2 2018, an estimated $546K.
  • PEAK6 Group first reported a position in Axcelis in Q3 2013 and held it in 6 quarters.
  • PEAK6 Group's Axcelis position peaked at $546K in Q1 2018.
  • 165 funds tracked by Wall St. Rank held Axcelis as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.